10.1016/j.arr.2023.101910 26 EbrahimiB.MokhtariT.GhaffariN.AdabiM.HassanzadehG
Only 20% of glargine-treated patients achieved the pre-specified target fasting plasma glucose of 100 mg/dL
Similarly, patients prescribed exenatide experienced a 32% reduced likelihood, those prescribed liraglutide had a 27% reduced likelihood, and those prescribed dulaglutide had a 23% reduced likelihood
Because the liposomal format protects the ingredient, more of it may reach your cells
Doege H, Baillie RA, Ortegon AM, Tsang B, Wu Q, Punreddy S, Hirsch D, Watson N, Gimeno RE, Stahl A (2006) Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis
Market Scope Segment Insights Drug Type Insights What made semaglutide the dominant segment in the obesity GLP-1 market